In recent trading session, Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) saw 3,940,008 shares changing hands with its beta currently measuring 0.98. Company’s recent per share price level of $9.22 trading at $1.63 or 21.41% at recent trade assigns it a market valuation of $1.49 Billion. That current trading price of MDRX’s stock is at a discount of -28.2% from its 52-week high price of $11.82 and is indicating a premium of 50.54% from its 52-week low price of $4.56. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.28 Million shares which gives us an average trading volume of 2.18 Million if we extend that period to 3-months.

For Allscripts Healthcare Solutions, Inc. (MDRX), analysts’ consensus is at an average recommendation of Hold while assigning it a mean rating of 2.6. Splitting up the data highlights that, out of 24 analysts covering the stock, 2 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 15 suggested the stock as a Hold whereas 6 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of $0.17 in the current quarter.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) trade information

Upright in the green today for gaining 21.41%, in the last five days MDRX remained trading in the green while hitting it’s week-highest on Friday, Jul 31 when the stock touched $10.49- price level, adding 13.92% to its value on the day. Allscripts Healthcare Solutions, Inc.’s shares saw a change of -8% in year-to-date performance and have moved 28.45% in past 5-day. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) showed a performance of 33.38% in past 30-days. Number of shares sold short was 19.03 Million shares which calculate 8.73 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $8.85 to the stock, which implies targetted prices is already lagging behind -4.01% to its current value. Analysts have been projecting $6 as a low price target for the stock while placing it at a high target of $14.5. It follows that stock’s current price would jump +57.27% in reaching the projected high whereas dropping to the targeted low would mean a loss of -34.92% for stock’s current value.

Allscripts Healthcare Solutions, Inc. (MDRX) estimates and forecasts

17 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $425.9 Million for the same. And 17 analysts are in estimates of company making revenue of $445.98 Million in the next quarter that will end in December 01, 2020. Company posted $444.6 Million and $451.5 Million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to drop by -4.2% while estimating it to be -1.2% for the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -24.7% during past 5 years. In 2020, company’s earnings growth rate is likely to be around -10.4% while estimates for its earnings growth in next 5 years are of 6.6%

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)’s Major holders

Insiders are in possession of 1.44% of company’s total shares while institution are holding 113.95% percent of that, with stock having share float percentage of 115.62%. Investors also watch the number of corporate investors in a company very closely, which is 327 institutions for Allscripts Healthcare Solutions, Inc. that are currently holding shares of the company. Wellington Management Company, LLP is the top institutional holder at MDRX for having 21.79 Million shares of worth $153.4 Million. And as of March 30, 2020, it was holding 13.41% of the company’s outstanding shares.

The second largest institutional holder is Blackrock Inc., which was holding about 20.87 Million shares on March 30, 2020. The number of shares represents firm’s hold over 12.84% of outstanding shares, having a total worth of $146.94 Million.

On the other hand, Vanguard Specialized-Health Care Fund and Undiscovered Managers Behavioral Value Fund are the top two Mutual Funds which own company’s shares. As of April 29, 2020, the former fund manager was holding 9845231 shares of worth $63.99 Million or 6.06% of the total outstanding shares. The later fund manager was in possession of 6.01 Million shares on March 30, 2020, making its stake of worth around $42.32 Million in the company or a holder of 3.7% of company’s stock.